沃森生物涨2.08%，成交额3.81亿元，主力资金净流出1874.83万元

Core Viewpoint - Watson Bio's stock has shown fluctuations with a recent increase of 2.08%, while the company faces a decline in revenue and profit year-on-year [1][2]. Group 1: Stock Performance - As of November 11, Watson Bio's stock price reached 12.75 CNY per share, with a market capitalization of 20.39 billion CNY [1]. - Year-to-date, the stock has increased by 5.63%, with a 3.41% rise over the last five trading days and an 11.94% increase over the last 20 days [1]. - The stock has experienced a decline of 3.56% over the past 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Watson Bio reported a revenue of 1.72 billion CNY, a year-on-year decrease of 19.73% [2]. - The net profit attributable to shareholders for the same period was 163 million CNY, reflecting a year-on-year decline of 36.24% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 2.75% to 114,000, while the average number of circulating shares per person increased by 2.83% to 13,643 shares [2]. - The company has distributed a total of 403 million CNY in dividends since its A-share listing, with 47.98 million CNY distributed over the last three years [3]. - The largest circulating shareholder is E Fund's ChiNext ETF, holding 34.47 million shares, a decrease of 5.80 million shares from the previous period [3].